Sudha Murthy awarded with Padma Bhushan, Biocon chief Kiran Mazumdar-Shaw calls her an 'inspiration'
The Padma Awards are one of the highest civilian honours of India announced annually on the eve of Republic Day. The Awards are given in three categories: Padma Vibhushan, Padma Bhushan, and Padma Shri.
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed the press release titled 'Biocon Foundation Wins the Prestigious 'IHW Gold Award for Diseases Screening Initiative of the Year' for 2022'. The above information will also be available on the website of the Company at www.biocon.com. BIOCON LTD. - 532523 - Voting Results And Scrutinizers Report On Postal Ballot
In Continuation to our letter dated December 20, 2022, seeking approval of the members by way of Postal Ballot through the remote e-voting process on the resolutions as set out in the Postal Ballot Notice dated December 19, 2022, please find enclosed: 1. Voting results pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulation'), enclosed and marked as 'Annexure-1'; 2. Scrutinizer's Report dated January 23, 2023, pursuant to Section 110 of the Companies Act, 2013 read with Rule 22 of the Companies (Management and Administration) Rules, 2014, enclosed and marked as 'Annexure-2'. BIOCON LTD. - 532523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to certify that the details of securities dematerialized and rematerialized during the quarter ended December 31, 2022, as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 have been furnished to all the Stock Exchanges where the shares of Biocon Limited are listed. The certificate from our RTA i.e. M/s. KFin Technologies Limited (Formerly known as KFin Technologies Private Limited) dated January 4, 2023, confirming the above, is enclosed for your reference. BIOCON LTD. - 532523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to certify that the details of securities dematerialized and rematerialized during the quarter ended December 31, 2022, as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 have been furnished to all the Stock Exchanges where the shares of Biocon Limited are listed. The certificate from our RTA i.e. M/s. KFin Technologies Limited (Formerly known as KFin Technologies Private Limited) dated January 4, 2023, confirming the above, is enclosed for your reference. BIOCON LTD. - 532523 - Company Statement
Please find below a Company Statement. 'The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for the Insulin-R product filed by Biocon Biologics. The CRL cites additional data required in the BLA submission and an expectation of a satisfactory implementation of a CAPA plan pertaining to the Pre-Approval Inspection of our Bangalore facilities in Aug'22. We are in the process of comprehensively addressing the CRL.' - Company Spokesperson, Biocon Biologics. The above information will also be available on the website of the Company at www.biocon.com. BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
The Company will organize an Earnings Conference Call for analysts/investors on Wednesday, February 15, 2023. The details of the same will be available on the Company's website closer to the scheduled event. BIOCON LTD. - 532523 - Closure of Trading Window
The trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading ('the Code') of the Company, has been closed from Sunday, January 1, 2023 to Thursday, February 16, 2023 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations, 2015. Accordingly, the trading window will open on Friday, February 17, 2023. BIOCON LTD. - 532523 - Board Meeting Intimation for Intimation For The Board Meeting
BIOCON LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 14, 2023, inter alia, to approve and take on record the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2022, amongst other routine matters. BIOCON LTD. - 532523 - Reminder Letter To Shareholders For Claiming Unclaimed Dividends.
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please note that the Company has sent reminder letter and has also informed via email to eligible shareholders on December 29, 2022, who have not claimed their dividend for any of the financial year, requesting them to claim the same. Copy of the reminder letter is enclosed herewith. The above information will also be available on the website of the Company at www.biocon.com.